Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Buy
3,714
+270
+8% +$24.6K 0.01% 353
2026
Q1
$354K Buy
3,444
+40
+1% +$4.52K 0.02% 308
2025
Q4
$426K Buy
3,404
+417
+14% +$53.1K 0.02% 264
2025
Q3
$400K Buy
2,987
+207
+7% +$27.2K 0.02% 246
2025
Q2
$378K Buy
2,780
+377
+16% +$49.7K 0.02% 245
2025
Q1
$319K Sell
2,403
-2,169
-47% -$276K 0.02% 254
2024
Q4
$517K Buy
4,572
+147
+3% +$17K 0.03% 203
2024
Q3
$504K Buy
4,425
+410
+10% +$45K 0.03% 197
2024
Q2
$417K Buy
4,015
+92
+2% +$9.75K 0.03% 194
2024
Q1
$446K Sell
3,923
-1,383
-26% -$159K 0.03% 179
2023
Q4
$584K Buy
5,306
+15
+0.3% +$1.5K 0.04% 146
2023
Q3
$512K Sell
5,291
-1,088
-17% -$114K 0.04% 154
2023
Q2
$695K Buy
6,379
+3,078
+93% +$328K 0.06% 131
2023
Q1
$334K Buy
+3,301
New +$349K 0.03% 188
2018
Q4
Sell
-1,179
Closed -$87K 67
2018
Q3
$87K Sell
1,179
-85
-7% -$5.58K 0.03% 121
2018
Q2
$77K Hold
1,264
0.03% 120
2018
Q1
$76K Buy
+1,264
New +$76.2K 0.03% 121

Other funds holding ABT

McAdam LLC's ABT Position: Q2 2026 in Review

McAdam LLC increased its Abbott (ABT) stake by 7.8% in Q2 2026, buying an estimated $24.6K and bringing the position to 3,714 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #353.

McAdam LLC first reported a position in ABT in Q1 2018 and has held it in 17 quarters since. The position peaked at $695K in Q2 2023. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • McAdam LLC held 3,714 shares of Abbott worth $337K as of Q2 2026.
  • McAdam LLC bought 270 Abbott shares in Q2 2026, an estimated $24.6K.
  • Abbott made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #353 holding.
  • McAdam LLC first reported a position in Abbott in Q1 2018 and has held it in 17 quarters since.
  • McAdam LLC's Abbott position peaked at $695K in Q2 2023.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.